Hemispherx Biopharma., has announced its for the first quarter of FY-2015. The results shows EPS remains stable -$0.02 YoY, whereas cash and cash Assets were improved from $16.108 Million to $17.005 Million YoY. View the full earnings release here.
Array BioPharma Inc., has announced its this quarter results for FY-2014-15. The Results shows Rise in EPS $0.37 from $0.11 YoY, Revenues were $6.6 Million which was expected at $6 million. View the full release here.